Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
613–648
Headlines
5371
Sources here
20
Companies here
28
Current section United States Medical Devices news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts

Analysts have given iRhythm Technologies (NASDAQ:IRTC) an average recommendation of "Moderate Buy," with a consensus price target of $179.93. The company recently reported strong quarterly earnings, beating expectations with an EPS of $0.58 and revenue of $224.17 million, a 20.1% year-over-year increase. Institutional investors, …

IRTC main company
Sharemaestro market context Price above Trend Line 52 weeks -25.2% IRTC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges

1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges Semiconductors are the silicon backbone of the digital revolution. The amount of data we ingest is also increasing exponentially, leading to elevated demand for chips with more processing power. This secular trend bodes well …

PHG mentioned
Sharemaestro market context Price above Trend Line 52 weeks +0.1% · Next-week setup positive 55.6% PHG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ATEC Stock Price and Chart — NASDAQ:ATEC

This article provides a detailed overview of Alphatec Holdings, Inc. (NASDAQ:ATEC) stock, including its current price, historical performance, key financial metrics, and analyst ratings. It highlights the company's focus on spinal fusion technology and reports its Q2 2026 earnings, showing revenue growth and increased …

ATEC main company
Sharemaestro market context Price below Trend Line 52 weeks -39.3% ATEC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

1 Cash-Heavy Stock with Exciting Potential and 2 We Question

1 Cash-Heavy Stock with Exciting Potential and 2 We Question Companies with more cash than debt can be financially resilient, but that doesn't mean they're all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers. …

INSP mentioned
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

SS Innovations International, Inc. (Nasdaq: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as its new Chief Financial Officer, effective August 3, 2026. Romano brings over two decades of experience in financial leadership, capital strategy, and corporate growth within the …

SSII main company
Sharemaestro market context Price below Trend Line 52 weeks -44.3% · Next-week setup negative 37.8% SSII stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock

Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems (NASDAQ:INSP), sold 963 shares of company stock for a total of $57,346. Following the sale, Mr. Kelly directly owns 18,985 shares. Despite the stock being down 36% year-to-date, InvestingPro analysis suggests the …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Owlet Inc (OWLT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic AI Expansion ...

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record Q2 total revenue of $33.9 million, up 29.9% year-over-year. Gross margin expanded to 54% …

OWLT main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% OWLT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ...

Mobia Medical Inc. (MOBI) reported a 102% year-over-year revenue increase to $13.5 million in Q2 2026, driven by an IPO that raised $134 million and expanded active territories. Despite the strong revenue growth and improved gross margin, the company's net loss widened to $21.0 …

MOBI main company
Sharemaestro market context Stored weekly price path 15 weeks +0.1% MOBI stored weekly price path from 8 May 2026 to 14 Aug 2026

SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

SINTX Technologies released its mid-year 2026 business update, detailing significant progress in commercializing its FDA-cleared SiNAPTIC® Foot & Ankle Implant System and expanding its industrial ceramics business with $3.2 million in new purchase orders. The company also raised $5.0 million in capital, completed construction …

SINT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.0% · Next-week setup negative 34.1% SINT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Edwards Lifesciences (EW) Insider Daniel Lippis Sells 619 Shares

Edwards Lifesciences insider Daniel Lippis sold 619 shares of EW stock for $92.03 per share on August 11, 2026, totaling approximately $56,966.57. This sale is part of a pattern of 37 insider sells and no buys over the last year. Despite the insider selling, …

EW main company
Sharemaestro market context Trend signal active 52 weeks +11.9% · Next-week setup negative 42.8% EW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tranche Update on MaxCyte, Inc.'s Equity Buyback Plan announced on May 12, 2026.

MaxCyte, Inc. has provided an update on its equity buyback plan announced on May 12, 2026. As of August 12, 2026, the company has repurchased 4,730,105 shares, representing 4.42% of its stock, for a total of $5.5 million. This repurchase completes the program initiated …

MXCT main company
Sharemaestro market context Trend signal active 52 weeks -7.0% · Next-week setup negative 39.3% MXCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake

Qiming funds have reported a significant ownership stake in Alamar Biosciences, Inc. (ALMR) through a Schedule 13G filing. Qiming Corporate GP VI, Ltd and related entities collectively hold 10.2% beneficial ownership, translating to 7,066,573 shares based on 69,311,186 shares outstanding as of April 30, …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings

Tandem Diabetes Care, Inc. (TNDM) presents a high-risk, high-reward investment opportunity in the medical devices industry, with analysts projecting a 25% potential upside and no sell ratings. Despite current financial challenges like negative EPS and free cash flow, the company is bullishly positioned above …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

908 Devices Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MASS) 2026-08-11

908 Devices Inc. (MASS) reported strong Q2 2026 results with a 23% revenue increase to $16.1 million, driven by demand from US state and local customers. The company significantly improved profitability, cutting adjusted EBITDA loss by over 50% year-over-year, and raised its full-year 2026 …

MASS main company
Sharemaestro market context Trend signal active 52 weeks +55.2% MASS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sintx Technologies Q2 2026 Earnings Call Transcript

Sintx Technologies reported significant revenue growth of 199% year-over-year in Q2 2026, reaching $452,000, driven by increased product sales and improved gross margins. The company highlighted over $3.2 million in new purchase orders for contract manufacturing and initial commercial revenue from its SINAPTIC Foot …

SINT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.0% · Next-week setup negative 34.1% SINT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.7% MDT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 4:30 p.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Patrick MilesExecutive Vice President and Chief Financial Officer - J. Todd Koning TAKEAWAYS Total Revenue -- $214 million in the second quarter, …

ATEC main company
Sharemaestro market context Price below Trend Line 52 weeks -39.3% ATEC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Owlet Q2 Earnings Call Highlights

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record Q2 total revenue of $33.9 million, up 29.9% year-over-year. Gross margin expanded to 54% …

OWLT main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% OWLT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical Ord Shs (FEED) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for ENvue Medical Ord Shs (FEED), detailing its stock performance, market capitalization, and a comparison with peer companies. The financial forecasting includes expected EPS, revenue, net profit, and EBIT. It highlights that the data was updated on August …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock

Inspire Medical Systems insider Jason Kelly sold 963 shares of the company's stock for approximately $57,346.65, reducing his holdings by 4.83%. The company recently reported better-than-expected quarterly earnings and revenue, but revenue was down 7.6% year-over-year. Analysts maintain a "Hold" rating on the stock …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SINTX Technologies Q2 Results: Revenue guidance set at $900K-$1.1M for Q3

SINTX Technologies (NASDAQ: SINT) announced strong commercial progress in mid-2026, securing $3.2 million in new industrial orders and expanding its orthopedic distributor network for the SiNAPTIC implant system. The company set Q3 2026 revenue guidance between $900K and $1.1 million and Q4 guidance between …

SINT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.0% · Next-week setup negative 34.1% SINT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in TransMedics Group, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of TransMedics Group, Inc. The ETFs are primarily small-cap and health technology focused, providing investors with diversified exposure to the company. The list includes details such as market value, weight of TransMedics stock, …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medtronic options activity shows heavy call buying ahead of September earnings

Ahead of its September 1 earnings, Medtronic (NYSE:MDT) has seen significant options activity, with call volume far outpacing puts. Nearly 19,000 contracts for a single $100 call option for September 2026 indicate strong bullish sentiment, suggesting traders anticipate a substantial upside surprise. This event-driven …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.7% MDT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CeriBell (CBLL) Stock Premium Rides High Margins Despite Deeper Losses

CeriBell (CBLL) stock saw a 10.4% increase after its Q2 earnings report, driven by headline growth in its high-margin medical device business, despite widened net losses. The company reported revenue of US$28.1m and a net loss of US$19.3m, with investors crediting progress in hospital …

CBLL main company
Sharemaestro market context Price above Trend Line 52 weeks +93.4% · Next-week setup negative 42.0% CBLL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DexCom’s 37.5% quarter puts CGM maker within 3.5% of its high as volume stays moderate

DexCom closed at $84.75 after a ninth week in an active Trend Signal, but participation is only 1.1x baseline and the signal mix is balanced rather than emphatic.

DXCM main company
Sharemaestro market context Trend signal active 52 weeks +9.1% DXCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring

Apyx Medical is leveraging the increasing demand for surgical aesthetic procedures, driven by GLP-1 weight-loss drugs, with its Renuvion technology and new AYON Body Contouring System. The company projects significant revenue growth for 2026 in surgical aesthetics and is focusing on expanding its product …

APYX main company
Sharemaestro market context Trend signal ended 52 weeks +45.0% APYX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring the 9.23% Potential Upside in the Booming Medical Devices Sector

UFP Technologies, Inc. (UFPT) is presented as an appealing investment opportunity in the medical devices sector, boasting a $2.52 billion market cap and strong revenue growth of 15.10%. The company specializes in designing and manufacturing solutions for various medical devices, including advanced wound care …

UFPT main company
Sharemaestro market context Trend signal active 52 weeks +42.5% UFPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Announces Reverse Stock Split to Maintain Listing

Tenon Medical, Inc. (TNON) has announced a 1-for-35 reverse stock split, effective August 10, 2026, to meet Nasdaq's minimum $1.00 per-share requirement and maintain its listing. The company specializes in medical devices for sacro-pelvic disorders, marketing the Catamaran and SImmetry+ SI Joint Fusion Systems. …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements …

PRCT main company
Sharemaestro market context Price below Trend Line 52 weeks -47.5% · Next-week setup negative 44.9% PRCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale

LivaNova PLC has reported a planned sale of 2,675 shares of common stock, stemming from the exercise of employee stock appreciation rights. The transaction, valued at $209,942.40, is scheduled for August 11, 2026, and will be executed through Merrill Lynch as a broker-assisted cashless …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context